TQA-3526

N/A

Report date: 2025/06/10 20:00:09
NME

Base Information

Drug NameTQA-3526
Drug Alias NameTQA-3526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonistsBile acids replacements
TargetsBile acid receptor FXRBile acids
Therapy Area/IndicationsHepatitisCholangitisLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co LtdLianyungang Runzhong Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical GroupJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitisCholangitisLiver Cirrhosis, Biliary

Other Information

ATC CodeN/A
Related LinksN/A